Recently, a new class (often referred to as SPRMs: selective progesterone receptor modulators) of progesterone receptor ligands with mixed agonist/antagonist properties has been described. Such compounds are envisaged, for example, as treatment for endometriosis, uterine fibroids, and leiomyomas. Existing SPRMs include Asoprisnil 1 and Uliprisnil acetate 2. In our hands, however, these compounds proved to have a predominantly or exclusively antagonistic in vitro profile, which may make this type of compound less attractive, for example, as contraceptives. We therefore aimed at a class of mixed-profile compounds that would show a more evenly balanced agonist/antagonist profile. A novel class of 11beta-[4-(heteroaryl)phenyl]-substituted pregnanes was identified that displayed the desired balance. Contrary to known SPRMs, this novel class of MPP (mixed-profile progestagen) was found to have a truly mixed activity, including a sizeable agonist component.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2008.01.010DOI Listing

Publication Analysis

Top Keywords

class mixed-profile
8
progesterone receptor
8
novel class
8
11-pyridinylphenylsteroids--a class
4
mixed-profile progesterone
4
progesterone agonists/antagonists
4
class
4
agonists/antagonists class
4
class referred
4
referred sprms
4

Similar Publications

Women Victims of Intimate Partner Violence and Intimate Partner Homicide: A Typology Based on Victimization Variables.

Psychosoc Interv

January 2023

Secretary of State for Security Ministry for Home Affairs Spain Secretary of State for Security, Ministry for Home Affairs, Spain.

Intimate partner violence against women (IPVAW) and intimate partner homicide against women (IPHAW) are multidimensional phenomena. The aim of this study was to identify typologies of Spanish IPHAW and IPVAW victims, based on the differences between their characteristics and the determinants of aggression. The sample consisted of 381 cases from the Spanish Integral Monitoring System in Cases of Gender Violence.

View Article and Find Full Text PDF

Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases.

Antimicrob Agents Chemother

April 2023

InBioS, Center for Protein Engineering, Biological Macromolecules, Department of Life Sciences, University of Liège, Liège, Belgium.

Three soluble single-domain fragments derived from the unique variable region of camelid heavy-chain antibodies (VHHs) against the CMY-2 β-lactamase behaved as inhibitors. The structure of the complex VHH cAb(254)/CMY-2 showed that the epitope is close to the active site and that the CDR3 of the VHH protrudes into the catalytic site. The β-lactamase inhibition pattern followed a mixed profile with a predominant noncompetitive component.

View Article and Find Full Text PDF
Article Synopsis
  • * Some schools focused on helping all students, including those who struggle, by providing good resources and inclusive practices.
  • * Other schools mostly tried to attract students from middle-class families and didn't do much to support vulnerable students, showing different strengths and weaknesses in their approaches.
View Article and Find Full Text PDF

11-(pyridinylphenyl)steroids--a new class of mixed-profile progesterone agonists/antagonists.

Bioorg Med Chem

March 2008

Department of Medicinal Chemistry, NV Organon, PO Box 20, 5340 BH Oss, The Netherlands.

Recently, a new class (often referred to as SPRMs: selective progesterone receptor modulators) of progesterone receptor ligands with mixed agonist/antagonist properties has been described. Such compounds are envisaged, for example, as treatment for endometriosis, uterine fibroids, and leiomyomas. Existing SPRMs include Asoprisnil 1 and Uliprisnil acetate 2.

View Article and Find Full Text PDF

Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.

J Am Soc Nephrol

January 2006

Institut National de la Santé Et de la Recherche Médicale (INSERM), Unité 643: "Immunointervention dans les Allo- et Xénotransplantations," and Institut de Transplantation Et de Recherche en Transplantation (ITERT), Nantes, France.

A substantial proportion of long-term kidney graft recipients, including those with a stable renal function in the absence of immunosuppressive therapy, present a skewed T cell receptor (TCR) Vbeta chain usage, essentially in the CD8+ subset. This study analyzed in more detail phenotypical and functional alterations of CD8+ lymphocytes in drug-free tolerant patients (DF-Tol) compared with recipients with chronic rejection (CR). Phenotyping revealed a significant increase in central memory and a decrease in effector CD8+ lymphocytes in DF-Tol versus CR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!